Special Interest Group
IMPORTANT DISCLAIMER–Unauthorized and Wrongful Use of ABLE Logo

Association of Biotechnology Led Enterprises - ABLE is a not-for-profit national forum that represents the Indian Biotechnology Sector.

Established in April 2003, after industry leaders felt a need to form an exclusive forum .....[More]
.....[More]
Interview with Dr. Ravikumar




Event : Enterprise Building and Innovation Workshop
-
Event : Enterprise Building and Innovation Workshop
-
Event : FBAE & ABLE-AG, Bangalore event - February 27, 2012
-
Event : 2nd North East Life Science Entrepreneurship Workshop
-
Event : Genepool
-
Event : Seminar on Intellectual Property, Global Practices and Patent Laws
-
Event : BioInvest - 2011
-
Event : BEST India 2009
BEST-India is aimed at encouraging young postgraduate and doctoral students in developing biotechnology entrepreneurship
Event : BEST India 2010
BEST-India is aimed at encouraging young postgraduate and doctoral students in developing biotechnology entrepreneurship
Event : Bio Chicago 2010
ABLE took part in the 2010 BIO International Convention, the global event for biotechnology, at the McCormick Place in Chicago, IL.
Event : BioInvest 2010
Event : Boot Camp- Intellectual Property 2011
Intellectual Property Rights Conference on "US, European and India Patent Law for Protection of Inventions in Pharma and Biotech"
Event : Workshop on The Millennium Biotech Policy II
The Karnataka government has announced a slew of incentives for the biotechnology sector.
Event : Genepool
Event : ABLE\'s High level conclave
-
Event : BEST 2011
-
Event : North East Entrepreneurship Development Workshop
Event : Bangalore India Bio 2011, India\'s Biggest Biotech Show
-
Event : Role of Industry-Academia Linkage in fostering Innovation in the Biotech ecosystem in Tamil Nadu
-
Event : Bio International Convention - 2011
-
 






Intas Pharma raises Rs 300 crore from ChrysCapital PE
Lupin to set up new plant at Nagpur,invests Rs 400 cr in 5 yrs
GoM on drug pricing to meet today
AstraZeneca’s Ardea Purchase May Be First of New Deals
Merck plans Rs 750-cr vaccine lab in India
FIPB clears Shantha Biotechnics’ Rs 514-cr proposal
Lupin resumes anti-diabetic drug sales in US after court nod
Lupin resumes sale of generic diabetes drug in US
Shasun Pharma targets Rs 2000 cr turnover in 3 yrs
Repairing damaged hearts by healing affected cells
Shantha Bio to supply cholera vaccine to Haiti
Drug makers critical of EU non-tariff barrier
Piramal acquires molecular imaging R&D portfolio of Bayer
Human stem cells engineered to seek out and kill HIV
GSK, Teva in talks to buy Micro Labs' India business
Drug-resistant malaria spreading faster and wider
The Bt show at 10
Stem cells market all set to grow: Study
Bangalore can boast of bio-research centre
Research centre opened at Biocon
Pharma majors block better deal for victims
Stempeutics scouts for strategic investor
Shasun Pharma: Product line, R&D edge to drive growth
Monsanto opens Rs 28 cr seed conditioning facility at Shamirpet
Piramal to raise R&D spend for cancer drugs' trials
PMEAC comes up with 3 pricing models to fix retail prices of 328 drugs
Rules to tackle illicit tobacco trade could hit medicines
Biocon to launch anti-cholesterol drug in US market from FY13
Pharma policy GoM to decide on price Control
India has highest number of MDR- TB cases in South East Asia
XCyton launches therapeutic decision support system
Budget 2012: No booster shot for biotech
Move over drugs, here come new-age nutraceuticals
Chikungunya biomarker offers hope for patients
Biotechnology sector worried over compulsory licence
India's first compulsory licence granted to Natco for Bayer's cancer drug
Soon, a stem cells jab to beat organ rejection
Shetkari Sanghatana joins Pro-Bt cotton chorus - March 14, 2012 Shetkari Sanghatana joins Pro-Bt cotton chorus - March 14, 2012
Sharad Joshi supports Bt Cotton, The Times of India -March 14, 2012
Bt cotton and farmers' suicide not linked: Joshi, Business Standard - March 14, 2012
PMO studies impact on consumers and industry
Ayurveda can cure modern ailments
industry needs tax break, policies to spur growth
India- US starts human trial on Kalazar Vaccines
Novozymes to bring cost-effective enzymes to make biofuels
WHO plans strategy shift with polio vaccines
Health ministry nod for Hib vaccine sought
Vaccine trial for kala azar soon
Vaccine cos look to govt for regulatory shot in arm
Patents + Font Resize - Lupin settles Glumetza patent litigation with Santarus and Depomed
Global experts to attend conference on agri biotech, Times of India - February 27, 2012
Agriculture scientists urge govt. to lift moratorium on Bt Brinjal, The Hindu - February 28, 2012
Experts demand ban on Bt Brinjal lifted, Deccan Chronicle - February 28, 2012
Experts demand ban on Bt Brinjal lifted, The Asian Age - February 28, 2012
Scientists unveil 'Bangalore Declaration' on biotech crops, Business Line - February 28, 2012
Moratorium on Bt-brinjal not based on actual scientific data: Scientists, DNA - February 28, 2012
Bangalore Declaration calls to remove checks on biotech R&D, Business Standard - February 28, 2012
Agri scientists urge govt to lift moratorium on Bt-brinjal, The Economic Times - February 28, 2012
Stem Cell implants for Parkinson's
Cardiac Stem cells can restore heart muscles, says study
ICAR proposes new Bt cotton project
Shantha Biotech eyes 5 in 1 vaccine re-launch by 2013
Pharma policy draft to be placed before GoM in 3 weeks
'Lack of regulation hurting biotech sector'
Biotech meets sheds light on health and wealth
Kiran Mazumdar Shaw- The 25 most influential people in Biopharma today
Novozymes in pact with Sea6 Energy
Turn Ideas into economic growth
How to usher in vaccinnovation in India
Brouhaha over Bt brinjal nothing but political: Herring Brouhaha over Bt brinjal nothing but political: Herring
US drug makers Eli Lilly, Jubilant Life call off joint venture
Merck uses R& D arm to grow flagship drugs
Money inflow intact, 4 pharma FDI plans Okayed
Soon, national body to procure, distributed organs
Found: Cells that can prevent spread of Cancer
How Lupin cracked the Japanese pharma market
Biotech Regulation Must not increase Monopolis
Genotypic Technology Puts its ERP on the Cloud
New CEO for Camson Biotech
Epilepsy gene Discovered
India on Virgil for new enemy from LOC, Poliovirus
A step Closer to HIV prevention
Gujrat to develop quick detection kit for fake drugs
Human Trial on HIV Vaccine get under way
Lupin gets FDA approval for generic Tricor Tablet
        
Patron Members
Sustaining Member
 
Affiliate Members
 
Copyright ABLE 2011